Healthcare products supplier Johnson & Johnson, New Brunswick, N.J., will create three new divisions aimed at growing business and boosting the companys lagging sales.
Under the plan, Sherilyn McCoy, currently group chairman for J&Js Ethicon subsidiary, will become worldwide chairwoman of the new surgical-care division, which will focus on new technologies. Nicholas Valeriani, presently worldwide chairman of medical devices and diagnostics, will head the new office of strategy and growth, which will identify untapped areas of business, and Donald Casey Jr., currently group chairman of the diabetes franchise, will become worldwide chairman of the new comprehensive-care group, which will develop chronic-disease treatment portfolios. McCoy and Casey will also become members of the companys executive committee.
The new divisions will become operational Jan. 1, according to a company new release.
In an unrelated change, J&Js worldwide chairman of pharmaceuticals, Joseph Scodari, will retire early next year. Christine Boon, vice chairman of the board of directors, will assume responsibility for the division, but will remain in her current position. -- by Shawn Rhea
What do you think? Post a comment on this article and share your opinion with other readers. Submit your letter to Modern Healthcare Online at [email protected]. Please be sure to include your hometown and state, along with your organization and title.